Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Priority Technology | PRTH | Jul 26, 2024 | 6.30 | -0.63 |
Priveterra Acquisition II | PMGM | Jul 26, 2024 | 11.05 | 0.00 |
Priveterra Acquisition II Unit | PMGMU | Jul 26, 2024 | 10.96 | 0.00 |
Privia Health Group | PRVA | Jul 26, 2024 | 20.46 | +2.35 |
Pro-Dex | PDEX | Jul 26, 2024 | 18.79 | -1.52 |
ProAssurance | PRA | Jul 26, 2024 | 11.76 | +1.64 |
Procaps Group | PROC | Jul 26, 2024 | 2.46 | -3.53 |
Procept BioRobotics | PRCT | Jul 26, 2024 | 61.87 | -3.93 |
Processa Pharmaceuticals | PCSA | Jul 26, 2024 | 1.67 | +0.53 |
Procore Technologies | PCOR | Jul 26, 2024 | 70.31 | +3.87 |
Procter & Gamble | PG | Jul 26, 2024 | 169.11 | +1.32 |
Professional Diversity Network | IPDN | Jul 26, 2024 | 0.51 | -2.59 |
Proficient Auto Logistics | PAL | Jul 26, 2024 | 19.41 | 0.00 |
Profire Energy | PFIE | Jul 26, 2024 | 1.58 | -1.86 |
Profound Medical | PROF | Jul 26, 2024 | 11.18 | +2.66 |
ProFrac A | ACDC | Jul 26, 2024 | 8.35 | +0.48 |
PROG | PRG | Jul 26, 2024 | 43.93 | +3.78 |
Progress Software | PRGS | Jul 26, 2024 | 57.89 | +0.78 |
Progressive | PGR | Jul 26, 2024 | 215.68 | +1.37 |
Progyny | PGNY | Jul 26, 2024 | 29.14 | +1.89 |
Project Energy Reimagined Acquisition A | PEGR | Jul 26, 2024 | 10.81 | -6.00 |
Project Energy Reimagined Acquisition Unit | PEGRU | Jul 26, 2024 | 10.10 | -2.88 |
ProKidney | PROK | Jul 26, 2024 | 2.45 | +2.08 |
Prologis | PLD | Jul 26, 2024 | 122.68 | +1.87 |
ProMIS Neurosciences | PMN | Jul 26, 2024 | 1.60 | -20.70 |
PropertyGuru | PGRU | Jul 26, 2024 | 6.44 | -0.16 |
ProPetro | PUMP | Jul 26, 2024 | 8.82 | -0.11 |
ProPhase Labs | PRPH | Jul 26, 2024 | 3.22 | +6.27 |
ProQR Therapeutics | PRQR | Jul 26, 2024 | 1.88 | -0.27 |
PROS | PRO | Jul 26, 2024 | 25.54 | -2.11 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.